
Drug Safety & Medical Communications
For Drug Safety and Medical Communications, please contact INTEGRATED THERAPEUTIC SOLUTIONS INC at the number: 1-888-236-5445. (for US market inquiries only)
Product Complaints
Please contact info(at)h2-pharma.com for any product complaint.
Ordering Questions
Please contact orders(at)h2-pharma.com for any ordering question.
XENICAL is indicated in combination with a reduced calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in:
The most commonly observed adverse events (incidence of ≥5% and twice that of placebo) were oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation and fecal incontinence. In general, the first occurrence of these events was within 3 months of starting therapy.
Report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch.
Patients and caregivers may also report side effects to the Safety Call Center at 1-888-236-5445.

CHEPLAPHARM is a family-owned pharmaceutical company, headquartered in Germany. We offer our branded products on a global level. By focusing on an internationally oriented Buy and Build Strategy, we generate annually increasing growth rates. The close collaboration with our business partners and our international subsidiaries allows CHEPLAPHARM to successfully realize its corporate strategy.

H2-Pharma, LLC is a privately owned and operated pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceuticals. H2‐Pharma has the experience and distribution infrastructure to market and distribute products across the spectrum, and do so with a level of personal service that is unmatched in the industry.